Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661438 · ClinicalTrials.gov registry record · NA
Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02661438 is a NA study that has completed, run by Bayer. The registered enrollment target is 46 participants.
The verdict
NCT02661438, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.
Interventions
- DRUG Placebo to Ciprofloxacin DPI (BAYQ3939)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-01-12 |
| Est. Completion | 2016-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661438
The ClinicalTrials.gov registry entry for NCT02661438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placebo to Ciprofloxacin DPI (BAYQ3939) is the first listed.
NCT02661438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02661438 about?
NCT02661438 is a clinical study titled "Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo". The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.
What is the current status of trial NCT02661438?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2016-01-12. Estimated completion is 2016-03-17.
What interventions are being tested in trial NCT02661438?
The interventions under investigation include: Placebo to Ciprofloxacin DPI (BAYQ3939) (DRUG).
Who is sponsoring clinical trial NCT02661438?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.